160 related articles for article (PubMed ID: 14720526)
1. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial.
Abizaid A; Costa MA; Blanchard D; Albertal M; Eltchaninoff H; Guagliumi G; Geert-Jan L; Abizaid AS; Sousa AG; Wuelfert E; Wietze L; Sousa JE; Serruys PW; Morice MC;
Eur Heart J; 2004 Jan; 25(2):107-12. PubMed ID: 14720526
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
[TBL] [Abstract][Full Text] [Related]
3. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries].
Devito FS; Sousa AG; Feres F; Abizaid AA; Staico R; Mattos LA; Tanajura LF; Abizaid AC; Chaves AJ; Sousa JE
Arq Bras Cardiol; 2006 Apr; 86(4):268-75. PubMed ID: 16680291
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; Gómez-Hospital JA; Sanmartín M; Bañuelos C; Moreno R; Escaned J; Fernández C; Costa MA; Fernández-Avilés F; Macaya C
Rev Esp Cardiol; 2006 Oct; 59(10):1000-7. PubMed ID: 17125709
[TBL] [Abstract][Full Text] [Related]
7. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
[TBL] [Abstract][Full Text] [Related]
9. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
Simsek C; Räber L; Magro M; Boersma E; Onuma Y; Stefanini GG; Zanchin T; Kalesan B; Wenaweser P; Jüni P; van Geuns RJ; van Domburg RT; Windecker S; Serruys PW
Int J Cardiol; 2013 Dec; 170(1):36-42. PubMed ID: 24196314
[TBL] [Abstract][Full Text] [Related]
11. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
Violini R; Musto C; De Felice F; Nazzaro MS; Cifarelli A; Petitti T; Fiorilli R
J Am Coll Cardiol; 2010 Feb; 55(8):810-4. PubMed ID: 20170821
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
[TBL] [Abstract][Full Text] [Related]
14. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC;
Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.
Iakovou I; Ge L; Michev I; Sangiorgi GM; Montorfano M; Airoldi F; Chieffo A; Stankovic G; Vitrella G; Carlino M; Corvaja N; Briguori C; Colombo A
J Am Coll Cardiol; 2004 Sep; 44(5):967-71. PubMed ID: 15337205
[TBL] [Abstract][Full Text] [Related]
17. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial.
van Hout BA; Serruys PW; Lemos PA; van den Brand MJ; van Es GA; Lindeboom WK; Morice MC
Heart; 2005 Apr; 91(4):507-12. PubMed ID: 15772214
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
[TBL] [Abstract][Full Text] [Related]
19. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
Novack V; Nguyen MC; Rooney M; Chacko R; Novack L; Pencina M; Apruzzese P; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
Am J Cardiol; 2010 Sep; 106(6):774-9. PubMed ID: 20816116
[TBL] [Abstract][Full Text] [Related]
20. One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
Baumgart D; Klauss V; Baer F; Hartmann F; Drexler H; Motz W; Klues H; Hofmann S; Völker W; Pfannebecker T; Stoll HP; Nickenig G;
J Am Coll Cardiol; 2007 Oct; 50(17):1627-34. PubMed ID: 17950142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
